Page 26 - T Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The peptide-based vaccine induces a T cell-dependent response

60, 65, you're more at risk. and then after 4-6 months the vaccine is waning. but i spoke to a doctor today on that fda advisory committee, and he thinks that the third and the fourth rt shot should be left for people most at risk and that younger people are getting enough protection with two shots. let me tell you quickly why the controversy and the confusion here. it's because we're with talking about antibody protection, and often -- you've still got your t-cells, your memory -- arthel: yeah, but doesn't that wear with off too? >> yeah, it wears off. so -- correct. that wears off too to som...

Dramatically after the first month, after vaccine or after boosting. and because of that, pfizer's data and extrapolating from an israeli safety data, you know, pfizer had requested the modification for five months. i anticipate moderna will likely do the same, but the fda of course has to review their data. but always keep in mind, the antibodies are going to decline. we know that they will. the other arms of the immune system, the b-cells, t-cells and things like that are things that should remain durable for quite some time. we're doing this realtime, but that's what will protect you from s...

>> hey, jesse, thanks for having me here. i think the deviation that we are witnessing f from science by the biden administration, by the cdc for the science is frankly on par with the intelligence failure at pearl harbor and i will tell you why. what is going on with this vaccine and with the virus is that we need immunity on an individual basis to fight it. the pathway to that immunity could be vaccination. the vaccine that was developed by operation warp speed is extremely effective at mountingv icg responses and prime t cells and it could be used as the dominant pathway by on immune

The cdc recommends isolation for most people who test positive for have been exposed to the virus, from five days to ten. during evidence people are most infectious in the early days of the illness. let's bring and doctor farney makary, johns hopkins bloomberg school of public health and fox news medical contributor. marty, welcome, good to see you. let's start with talking about the omicron variant where we are, these new studies about t cells and how they seem to be very active against the omicron variant and maybe reducing the severity of covid. >> we got a lot of good news this week, a stu...